Specifically, we found a tumor promoting role of CysLT1R in a mouse model of colitis, i.e., AOM/DSS-induced colitis-associated colon cancer (CAC), and in a model of spontaneous CC (APCMin/+). Here, CYSLTR1 is linked to colitis.